239 related articles for article (PubMed ID: 17287821)
1. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
2. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D
Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344
[TBL] [Abstract][Full Text] [Related]
3. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
[TBL] [Abstract][Full Text] [Related]
4. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain.
Porcella A; Gessa GL; Pani L
Eur J Neurosci; 1998 May; 10(5):1743-51. PubMed ID: 9751146
[TBL] [Abstract][Full Text] [Related]
5. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
Katsidoni V; Kastellakis A; Panagis G
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats.
Braida D; Limonta V; Malabarba L; Zani A; Sala M
Eur J Pharmacol; 2007 Jan; 555(2-3):156-63. PubMed ID: 17116299
[TBL] [Abstract][Full Text] [Related]
7. Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study.
Acquas E; Pisanu A; Marrocu P; Goldberg SR; Di Chiara G
Eur J Pharmacol; 2001 May; 419(2-3):155-61. PubMed ID: 11426837
[TBL] [Abstract][Full Text] [Related]
8. Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice.
Senn R; Keren O; Hefetz A; Sarne Y
Pharmacol Biochem Behav; 2008 Jan; 88(3):230-7. PubMed ID: 17888506
[TBL] [Abstract][Full Text] [Related]
9. Effect of delta9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test.
Jarrett MM; Scantlebury J; Parker LA
Physiol Behav; 2007 Feb; 90(2-3):425-30. PubMed ID: 17118412
[TBL] [Abstract][Full Text] [Related]
10. Changes in phosphorylation of CREB, ERK, and c-fos induction in rat ventral tegmental area, hippocampus and prefrontal cortex after conditioned place preference induced by chemical stimulation of lateral hypothalamus.
Haghparast A; Taslimi Z; Ramin M; Azizi P; Khodagholi F; Hassanpour-Ezatti M
Behav Brain Res; 2011 Jun; 220(1):112-8. PubMed ID: 21295078
[TBL] [Abstract][Full Text] [Related]
11. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats.
Malone DT; Taylor DA
Behav Brain Res; 2006 Jan; 166(1):101-9. PubMed ID: 16143410
[TBL] [Abstract][Full Text] [Related]
12. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
Freedland CS; Whitlow CT; Miller MD; Porrino LJ
Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
[TBL] [Abstract][Full Text] [Related]
14. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
15. Effects of delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress.
Fokos S; Panagis G
J Psychopharmacol; 2010 May; 24(5):767-77. PubMed ID: 19406854
[TBL] [Abstract][Full Text] [Related]
16. Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.
Rubino T; Vigano' D; Realini N; Guidali C; Braida D; Capurro V; Castiglioni C; Cherubino F; Romualdi P; Candeletti S; Sala M; Parolaro D
Neuropsychopharmacology; 2008 Oct; 33(11):2760-71. PubMed ID: 18172430
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
18. Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats.
Shoji H; Mizoguchi K
J Ethnopharmacol; 2013 Aug; 149(1):93-102. PubMed ID: 23770052
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain.
Allen KV; McGregor IS; Hunt GE; Singh ME; Mallet PE
Neuropharmacology; 2003 Feb; 44(2):264-74. PubMed ID: 12623225
[TBL] [Abstract][Full Text] [Related]
20. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme.
Blázquez C; Sánchez C; Daza A; Galve-Roperh I; Guzmán M
J Neurochem; 1999 Apr; 72(4):1759-68. PubMed ID: 10098887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]